Table 4.
Pathological stage | Number | Gleason scores | Recurrent | *PC free* | Undetermined outcome+ |
---|---|---|---|---|---|
T2a | 5 | 5–7 | 3/7 | 2/7 | 2/7 |
T2b | 115 | 6–10 | 45/115 | 69/115 | 1/115 |
T2c | 2 | 5,7 | 1/2 | 1/2 | 0/2 |
T3a | 23 | 6–8 | 11/23 | 12/23 | 0/23 |
T3b | 14 | 7–9 | 7/14 | 7/14 | 0/14 |
T3c | 1 | 7 | 0/1 | 1/1 | 0/1 |
T4 | 3 | 8 | 0/3 | 3/3 | 0/3 |
- clinical follow-up for 5 years;
- No adequate clinical follow-up.